These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 17154704)
1. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. Duda SH; Bosiers M; Lammer J; Scheinert D; Zeller T; Oliva V; Tielbeek A; Anderson J; Wiesinger B; Tepe G; Lansky A; Jaff MR; Mudde C; Tielemans H; Beregi JP J Endovasc Ther; 2006 Dec; 13(6):701-10. PubMed ID: 17154704 [TBL] [Abstract][Full Text] [Related]
2. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. Duda SH; Bosiers M; Lammer J; Scheinert D; Zeller T; Tielbeek A; Anderson J; Wiesinger B; Tepe G; Lansky A; Mudde C; Tielemans H; Bérégi JP J Vasc Interv Radiol; 2005 Mar; 16(3):331-8. PubMed ID: 15758128 [TBL] [Abstract][Full Text] [Related]
3. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. Geraghty PJ; Mewissen MW; Jaff MR; Ansel GM; J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191 [TBL] [Abstract][Full Text] [Related]
4. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445 [TBL] [Abstract][Full Text] [Related]
5. Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. Schlager O; Dick P; Sabeti S; Amighi J; Mlekusch W; Minar E; Schillinger M J Endovasc Ther; 2005 Dec; 12(6):676-84. PubMed ID: 16363897 [TBL] [Abstract][Full Text] [Related]
12. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. Farraj N; Srivastava A; Pershad A J Invasive Cardiol; 2009 Jun; 21(6):278-81. PubMed ID: 19494404 [TBL] [Abstract][Full Text] [Related]
13. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342 [TBL] [Abstract][Full Text] [Related]
14. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Dick P; Wallner H; Sabeti S; Loewe C; Mlekusch W; Lammer J; Koppensteiner R; Minar E; Schillinger M Catheter Cardiovasc Interv; 2009 Dec; 74(7):1090-5. PubMed ID: 19859954 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial. Nasser F; Kambara A; Abath C; Cavalcanti D; Barros I; Pires N; Rivera M; Neser A; Ingrund J; Burihan M; Silveira P; Galego G; Bortoluzzi C; Franklin R; Bosiers M; Deloose K; Razuk A; Caffaro R; Karakhanian WK; Park J; Lopes C; Pinto D; Bez L; Lopes R; Mourão A; Kleinsorge G J Cardiovasc Surg (Torino); 2017 Jun; 58(3):409-415. PubMed ID: 25731858 [TBL] [Abstract][Full Text] [Related]
16. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768 [TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [TBL] [Abstract][Full Text] [Related]
18. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial. Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672 [TBL] [Abstract][Full Text] [Related]
19. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. Bosiers M; Torsello G; Gissler HM; Ruef J; Müller-Hülsbeck S; Jahnke T; Peeters P; Daenens K; Lammer J; Schroë H; Mathias K; Koppensteiner R; Vermassen F; Scheinert D J Endovasc Ther; 2009 Jun; 16(3):261-9. PubMed ID: 19642788 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]